Class III · Lower riskRecall completed
Metoprolol Tartrate Injection
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberLot #: A0A0253, Exp. 02/2019; Lot #: B0369427-112717, Exp. 08/2019
Where it was sold1 vial was distributed to a medical facility in Mayville, NY.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | RemedyRepack Inc. |
| NDC | 70518-0868-00 |
Show the full FDA record
| Full product label | Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00 |
| Recalling firm | RemedyRepack Inc. |
| Distribution | 1 vial was distributed to a medical facility in Mayville, NY. |
| Quantity | 1 vial |
| Recall initiated | 2018-10-26 |
| Report date | 2018-11-21 |
| Recall completed | 2019-02-05 |
| Recall number | D-0245-2019 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Indiana PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.